IND 32095 is Immuron's Investigational new drug (IND) application for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) and is now ...
Combining “complementary” audio technology could speed the adoption of the immersive Atmos sound format, a Dolby exec says. By Carolyn Giardina Former Tech Editor Dolby Laboratories has acquired rival ...
In a domestic mergers and acquisitions market gripped by a deal drought this year, IMM Private Equity demonstrated its ...
(RTTNews) - Immuneering Corp. (IMRX) on Thursday, announced that its lead drug candidate, IMM-1-104, has been granted Fast Track designation by the FDA as a treatment for patients with unresectable or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results